A Phase I And Pharmacokinetic Study of Intravenous Phenylacetate in Patients with Cancer

Cancer Research

Volumn 54, Issue 7, 1994, Pages 1690-1694

  Thibault, Alain ^a   Cooper, Michael R ^a   Figg, William D ^a   Venzon, David J ^a   Sartor, A Oliver ^a   Tompkins, Anne C ^a   Weinberger, Maribeth S ^a   Headlee, Donna J ^a   McCall, Natalie A ^a   Samid, Dvorit ^a   Myers, Charles E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; PHENYLACETIC ACID; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ION EXCHANGE CHROMATOGRAPHY; MALE; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROSTATE CANCER; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; GLUTAMINE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; PHENYLACETATES;

EID: 0028269683     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sandler, M. Ruthven, C.R.J. Goodwin, B.L. Lee, A. and Stern, G.M. Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values. J. Neurol. Neurosurg. Psychol. 45: 366-368, 1982.
2. Brusilow, S.W. Danney, M. Waber, L.J. Batshaw, M. Burton, B. Levitsky, L. Roth, K. McKeethren, C. and Ward, J. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med. 310: 1630-1634, 1984.
3. Simell, O. Sipila, I. Rajantie, J. Valle, D.L. and Brusilow, S.W. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance. Pediatr. Res. 20: 1117-1121, 1986.
4. Watson. A.J. Karp, J.E. Walker, W.G. Chambers, T. Risen, V.R. and Brusilow, S.W. Transient idiopathic hyperammonaemia in adults. Lancet, 2: 1271-1274, 1985.
5. Mendenhall, C.L. Rouster, S. Marshall, L. and Weesner, R. A new therapy for portal systemic encephalopathy. Am. J. Gastroenterol. 81: 540-543, 1986.
6. Moldave, K. and Meister, A. Synthesis of phenylacetylglutamine by human tissue. J. Biol. Chem. 229: 463-476, 1957.
7. James, M.O. Smith, R.L. Williams, F.R.S. and Reidenberg, M. The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc. R. Soc. Lond. Ser. B. 182: 25-35, 1972.
8. Samid, A. Shack, S. and Sherman, L.T. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res. 52: 1988-1992, 1992.
9. Samid, D. Yeh, A. and Prasana, P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood, 80: 1576-1581, 1992.
10. Samid, D. Shack, S. and Myers, C.E. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J. Clin. Invest. 91: 2288-2295, 1993.
11. Samid. D. Ram, Z. Hudgins, W.R. Shack, S. Liu, L. Walbridge, S. Oldfield, E.H. Myers, C.E. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res. 54: 891-895, 1994.
12. Dover, G.J. Brusilow, S. and Samid, D. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N. Engl. J. Med. 327: 569-570, 1992.
13. Burzynski, S.R. Kubove E. Burzynski, B. Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1. Drugs Exp. Clin. Res. 16: 361-369, 1990.
14. Wilcoxon, F. Individual comparisons by ranking methods. Biometrics, 1: 80-83, 1945.
15. Shapiro, S.S. and Wilk, M.B. An analysis of variance test for normality (complete samples). Biometrika, 52: 591-611, 1965.
16. Draper, N.R. and Smith, H. Applied Regression Analysis, p. 282. New York: John Wiley and Sons, Inc. 1966.